- Home
- CLLS vs QUAD Comparison
CLLS vs QUAD Comparison
Compare CLLS & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- QUAD
- Stock Information
- Founded
- CLLS 1999
- QUAD 1971
- Country
- CLLS France
- QUAD United States
- Employees
- CLLS N/A
- QUAD N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- QUAD Publishing
- Sector
- CLLS Health Care
- QUAD Consumer Discretionary
- Exchange
- CLLS Nasdaq
- QUAD Nasdaq
- Market Cap
- CLLS 164.2M
- QUAD 393.5M
- IPO Year
- CLLS 2007
- QUAD 2010
- Fundamental
- Price
- CLLS $1.71
- QUAD $6.86
- Analyst Decision
- CLLS Buy
- QUAD Strong Buy
- Analyst Count
- CLLS 3
- QUAD 2
- Target Price
- CLLS $7.00
- QUAD $10.15
- AVG Volume (30 Days)
- CLLS 54.8K
- QUAD 352.9K
- Earning Date
- CLLS 11-04-2024
- QUAD 02-18-2025
- Dividend Yield
- CLLS N/A
- QUAD 2.84%
- EPS Growth
- CLLS N/A
- QUAD N/A
- EPS
- CLLS N/A
- QUAD N/A
- Revenue
- CLLS $36,042,000.00
- QUAD $2,751,700,000.00
- Revenue This Year
- CLLS $271.02
- QUAD N/A
- Revenue Next Year
- CLLS $33.48
- QUAD N/A
- P/E Ratio
- CLLS N/A
- QUAD N/A
- Revenue Growth
- CLLS 46.96
- QUAD N/A
- 52 Week Low
- CLLS $1.41
- QUAD $4.06
- 52 Week High
- CLLS $3.38
- QUAD $9.13
- Technical
- Relative Strength Index (RSI)
- CLLS 36.61
- QUAD 37.42
- Support Level
- CLLS $1.41
- QUAD $7.30
- Resistance Level
- CLLS $1.64
- QUAD $7.58
- Average True Range (ATR)
- CLLS 0.10
- QUAD 0.36
- MACD
- CLLS -0.03
- QUAD -0.19
- Stochastic Oscillator
- CLLS 19.09
- QUAD 3.41
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About QUAD Quad Graphics Inc
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.